Literature DB >> 2677113

The Duchenne dystrophy story: from phenotype to gene and potential treatment.

V Dubowitz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2677113     DOI： 10.1177/088307388900400402

Source DB:  PubMed          Journal:  J Child Neurol        ISSN： 0883-0738            Impact factor:   1.987


× No keyword cloud information.
  10 in total

Review 1.  Molecular biology of neurological diseases.

Authors:  W J Cumming
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

2.  Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes.

Authors:  R G Roberts; T F Barby; E Manners; M Bobrow; D R Bentley
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

3.  Upper extremity 3-dimensional reachable workspace analysis in dystrophinopathy using Kinect.

Authors:  Jay J Han; Gregorij Kurillo; Richard T Abresch; Evan De Bie; Alina Nicorici; Ruzena Bajcsy
Journal:  Muscle Nerve       Date:  2015-06-03       Impact factor: 3.217

Review 4.  Pharmacology and toxicology of eteplirsen and SRP-5051 for DMD exon 51 skipping: an update.

Authors:  Omar Sheikh; Toshifumi Yokota
Journal:  Arch Toxicol       Date:  2021-11-19       Impact factor: 5.153

Review 5.  Restoring Protein Expression in Neuromuscular Conditions: A Review Assessing the Current State of Exon Skipping/Inclusion and Gene Therapies for Duchenne Muscular Dystrophy and Spinal Muscular Atrophy.

Authors:  Omar Sheikh; Toshifumi Yokota
Journal:  BioDrugs       Date:  2021-06-07       Impact factor: 5.807

6.  Deletion mutations in Duchenne muscular dystrophy (DMD) in Western Saudi children.

Authors:  Mohammed T Tayeb
Journal:  Saudi J Biol Sci       Date:  2010-04-13       Impact factor: 4.219

7.  Dystrophin in frameshift deletion patients with Becker muscular dystrophy.

Authors:  S B Gangopadhyay; T G Sherratt; J Z Heckmatt; V Dubowitz; G Miller; M Shokeir; P N Ray; P N Strong; R G Worton
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

Review 8.  The golden retriever model of Duchenne muscular dystrophy.

Authors:  Joe N Kornegay
Journal:  Skelet Muscle       Date:  2017-05-19       Impact factor: 4.912

Review 9.  Drug development progress in duchenne muscular dystrophy.

Authors:  Jiexin Deng; Junshi Zhang; Keli Shi; Zhigang Liu
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

10.  Deletion of Dystrophin In-Frame Exon 5 Leads to a Severe Phenotype: Guidance for Exon Skipping Strategies.

Authors:  Zhi Yon Charles Toh; May Thandar Aung-Htut; Gavin Pinniger; Abbie M Adams; Sudarsan Krishnaswarmy; Brenda L Wong; Sue Fletcher; Steve D Wilton
Journal:  PLoS One       Date:  2016-01-08       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.